Back

Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice

26 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Statins, bempedoic acid and ezetimibe: novel findings Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Francois Schiele

Regional University Hospital Jean Minjoz, Besancon (France)

6 More presentations in this session

Presentation thumbnail
The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial
Associate Professor S. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis
Mrs N. Soroush (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021
Doctor G. Tan (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Statins, bempedoic acid and ezetimibe: novel findings

The Event

Event poster

ESC Congress 2023

26 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
LDL on target - strike early and strike strong... just strike...
thumbnail
Congress Presentation
Strike early and strong: lipid-lowering
thumbnail
Congress Presentation
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources